Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response —The final results of the D-first study

Source: Leukemia Research - Category: Hematology Authors: Tags: Research paper Source Type: research
More News: Hematology | Leukemia | Study